Pharmacological Management of Treatment-Resistant Obsessive-Compulsive DisorderAnat Abudy, Alzbeta Juven‐Wetzler, Joseph Zohar2011-06-25reviewCNS Drugs116 citationsclosedNo readable copy stored yet — this record is metadata only.Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesAbstractNo abstract was published for this record.Citations in this libraryStored only when both papers are in the corpus — 116 citations exist upstream.References2013Diagnostic and Statistical Manual of Mental Disorders1989The Yale-Brown Obsessive Compulsive Scale2004Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder2008Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder2009Obsessive-compulsive disorder2007Quality of life in the anxiety disorders: A meta-analytic review2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive DisorderCited by2012EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)